PIN37 COST-UTILITY OF ALFAPEGINTERFERON-2A (40 KD) IN CO-INFECTED PATIENTS IN THE PRIVATE HEALTH CARE SYSTEM IN BRAZIL
Abstract
Authors
D Crespo R Parana H Sette H Cheinquer F Barros MG Saggia EA Santos R Simoes
D Crespo R Parana H Sette H Cheinquer F Barros MG Saggia EA Santos R Simoes
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now